Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report)’s stock price dropped 2.5% during mid-day trading on Tuesday . The company traded as low as $0.56 and last traded at $0.60. Approximately 231,676 shares were traded during trading, a decline of 76% from the average daily volume of 948,409 shares. The stock had previously closed at $0.61.
Azitra Stock Performance
The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.01.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported ($2.74) EPS for the quarter, missing the consensus estimate of ($2.59) by ($0.15). The company had revenue of $0.01 million during the quarter. As a group, equities analysts predict that Azitra, Inc. will post -3.06 earnings per share for the current fiscal year.
Azitra Company Profile
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Further Reading
- Five stocks we like better than Azitra
- 3 Grocery Stocks That Are Proving They Are Still Essential
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
